Saturday, June 13, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 1022 of 1,261
  1. US 7598412

    Modulators of ATP-binding cassette transporters

    Vertex Pharmaceuticals Incorporated · Granted Oct 6, 2009 · Expires Oct 1, 2029

    granted
  2. US 7598396

    Crystalline solids of carvedilol and processes for their preparation

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Oct 6, 2009 · Expires Oct 1, 2029

    granted
  3. US 7598338

    Methods for the formation of hydrogels using thiosulfonate compositions and uses thereof

    Nektar Therapeutics · Granted Oct 6, 2009 · Expires Oct 1, 2029

    granted
  4. US 7598245

    Aminotriazole compounds useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Oct 6, 2009 · Expires Oct 1, 2029

    granted
  5. US 7598280

    Heterocyclic compounds, compositions comprising them and methods of their use

    LEXICON PHARMACEUTICALS, INC. · Granted Oct 6, 2009 · Expires Oct 1, 2029

    granted
  6. US 7598077

    Compositions and methods for enhancing differential expression

    The United States of America, as represented by the Department of Health and Human Services · Granted Oct 6, 2009 · Expires Oct 1, 2029

    granted
  7. US 7598048

    Screening methods for identifying agents that modulate output of a circadian pacemaker

    The Regents of the University of California · Granted Oct 6, 2009 · Expires Oct 1, 2029

    granted
  8. AU 2008353468

    Solid forms comprising (+)-2- [1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl] -4-acetylaminoisoindoline-1,3-dione, compositions thereof, and uses thereof

    CELGENE CORP [CH] · Granted Oct 1, 2009 · Expires Sep 26, 2029

    granted
  9. US 7595060

    Yeast-antigen compositions methods of making the same

    The Regents of the University of Colorado · Granted Sep 29, 2009 · Expires Sep 24, 2029

    granted
  10. US 7595047

    Compositions and methods for promoting or inhibiting angiogenesis

    Northwestern University · Granted Sep 29, 2009 · Expires Sep 24, 2029

    granted
  11. US 7595326

    Synthesis of novel tubulin polymerization inhibitors: benzoylphenylurea (BPU) sulfur analogs

    Champions Biotechnology, Inc · Granted Sep 29, 2009 · Expires Sep 24, 2029

    granted
  12. US 7595191

    Isolation and purification of P. falciparum merozoite protein-142 vaccine

    The United States of America as represented by the Secretary of the Army · Granted Sep 29, 2009 · Expires Sep 24, 2029

    granted
  13. US 7595333

    Agent for improving acidosis

    Takeda Pharmaceutical Company Limited · Granted Sep 29, 2009 · Expires Sep 24, 2029

    granted
  14. US 7595431

    Mouse models of human prostate cancer

    The Regents of the University of California · Granted Sep 29, 2009 · Expires Sep 24, 2029

    granted
  15. US 2009239858

    THERAPEUTIC AMIDES

    ALLERGAN INC [US] · Granted Sep 24, 2009 · Expires Sep 19, 2029

    granted
  16. US 7592368

    Sulphonamide derivatives as prodrugs of aspartyl protease inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Sep 22, 2009 · Expires Sep 17, 2029

    granted
  17. US 7591995

    Cobalamin conjugates useful as imaging and therapeutic agents

    Regents of the University of Minnesota · Granted Sep 22, 2009 · Expires Sep 17, 2029

    granted
  18. US 7592016

    Methods for preparing and using implantable substance delivery devices

    The Regents of the University of California · Granted Sep 22, 2009 · Expires Sep 17, 2029

    granted
  19. US 7592322

    RNAi modulation of RSV, PIV and other respiratory viruses and uses thereof

    Alnylam Pharmaceuticals, Inc. · Granted Sep 22, 2009 · Expires Sep 17, 2029

    granted
  20. US 7592355

    Quinolinone-carboxamide compounds as 5-HT, receptor agonists

    Theravance, Inc. · Granted Sep 22, 2009 · Expires Sep 17, 2029

    granted
  21. US 7592343

    Pyridazine-piperazine compounds and their use as stearoyl-CoA desaturase inhibitors

    Xenon Pharmaceuticals Inc. · Granted Sep 22, 2009 · Expires Sep 17, 2029

    granted
  22. US 7592453

    Fused quinoline derivative and use thereof

    Takeda Pharmaceutical Company Limited · Granted Sep 22, 2009 · Expires Sep 17, 2029

    granted
  23. US 7592340

    Quinoxalines useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Sep 22, 2009 · Expires Sep 17, 2029

    granted
  24. US 7589214

    Thiazoles, imidazoles, and pyrazoles useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Sep 15, 2009 · Expires Sep 10, 2029

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.